Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapy

Saved in:
Bibliographic Details
Other Authors: Prinzhorn, Wiltrud (Other) , Kleiner, Helga (Other) , Weiß, Christel (Other) , Müller, Martin Christian (Other) , Hehlmann, Rüdiger (Other) , Hofmann, Wolf-Karsten (Other) , Fabarius, Alice (Other) , Seifarth, Wolfgang (Other)
Format: Article (Journal)
Language:English
Published: 2015
In: PLOS ONE
Year: 2015, Volume: 10, Issue: 6
ISSN:1932-6203
DOI:10.1371/journal.pone.0129648
Online Access:Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1371/journal.pone.0129648
Get full text
Author Notes:Wiltrud Haaß; Helga Kleiner; Christel Weiß; Claudia Haferlach; Brigitte Schlegelberger; Martin C. Müller; Rüdiger Hehlmann; Wolf-Karsten Hofmann; Alice Fabarius; Wolfgang Seifarth; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group

MARC

LEADER 00000caa a2200000 c 4500
001 1514738422
003 DE-627
005 20220603142219.0
007 cr uuu---uuuuu
008 150827s2015 xx |||||o 00| ||eng c
024 7 |a 10.1371/journal.pone.0129648  |2 doi 
035 |a (DE-627)1514738422 
035 |a (DE-576)444738428 
035 |a (DE-599)BSZ444738428 
035 |a (OCoLC)1263738004 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
084 |a 33  |2 sdnb 
245 0 0 |a Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapy  |c Wiltrud Haaß; Helga Kleiner; Christel Weiß; Claudia Haferlach; Brigitte Schlegelberger; Martin C. Müller; Rüdiger Hehlmann; Wolf-Karsten Hofmann; Alice Fabarius; Wolfgang Seifarth; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group 
264 1 |c 2015 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.08.2015 
700 1 |a Prinzhorn, Wiltrud  |0 (DE-588)1035534924  |0 (DE-627)749547960  |0 (DE-576)383265703  |4 oth 
700 1 |a Kleiner, Helga  |0 (DE-588)1075839017  |0 (DE-627)833987380  |0 (DE-576)444702644  |4 oth 
700 1 |a Weiß, Christel  |d 1958-  |0 (DE-588)123287707  |0 (DE-627)082463417  |0 (DE-576)168356104  |4 oth 
700 1 |a Müller, Martin Christian  |d 1972-  |0 (DE-588)121360296  |0 (DE-627)705409236  |0 (DE-576)181482819  |4 oth 
700 1 |a Hehlmann, Rüdiger  |d 1941-  |0 (DE-588)1037003489  |0 (DE-627)751737879  |0 (DE-576)390939463  |4 oth 
700 1 |a Hofmann, Wolf-Karsten  |d 1967-  |0 (DE-588)114154635  |0 (DE-627)691208751  |0 (DE-576)351568336  |4 oth 
700 1 |a Fabarius, Alice  |d 1965-  |0 (DE-588)1037001281  |0 (DE-627)751728314  |0 (DE-576)390896667  |4 oth 
700 1 |a Seifarth, Wolfgang  |d 1960-  |0 (DE-588)1042491887  |0 (DE-627)769066453  |0 (DE-576)393988899  |4 oth 
773 0 8 |i In  |t PLOS ONE  |d San Francisco, California, US : PLOS, 2006  |g 10(2015,6) Artikel-Nr. e0129648, 18 S.  |h Online-Ressource  |w (DE-627)523574592  |w (DE-600)2267670-3  |w (DE-576)281331979  |x 1932-6203  |7 nnas  |a Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapy 
773 1 8 |g volume:10  |g year:2015  |g number:6  |g extent:18  |a Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapy 
856 4 0 |u http://dx.doi.org/10.1371/journal.pone.0129648  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20150827 
993 |a Article 
994 |a 2015 
998 |g 1042491887  |a Seifarth, Wolfgang  |m 1042491887:Seifarth, Wolfgang  |d 60000  |d 61200  |e 60000PS1042491887  |e 61200PS1042491887  |k 0/60000/  |k 1/60000/61200/  |p 10  |y j 
998 |g 1037001281  |a Fabarius, Alice  |m 1037001281:Fabarius, Alice  |d 60000  |d 61200  |e 60000PF1037001281  |e 61200PF1037001281  |k 0/60000/  |k 1/60000/61200/  |p 9 
998 |g 114154635  |a Hofmann, Wolf-Karsten  |m 114154635:Hofmann, Wolf-Karsten  |d 60000  |d 61200  |e 60000PH114154635  |e 61200PH114154635  |k 0/60000/  |k 1/60000/61200/  |p 8 
998 |g 1037003489  |a Hehlmann, Rüdiger  |m 1037003489:Hehlmann, Rüdiger  |d 60000  |e 60000PH1037003489  |k 0/60000/  |p 7 
998 |g 121360296  |a Müller, Martin Christian  |m 121360296:Müller, Martin Christian  |d 60000  |d 61200  |e 60000PM121360296  |e 61200PM121360296  |k 0/60000/  |k 1/60000/61200/  |p 6 
998 |g 123287707  |a Weiß, Christel  |m 123287707:Weiß, Christel  |d 60000  |d 60200  |d 60250  |e 60000PW123287707  |e 60200PW123287707  |e 60250PW123287707  |k 0/60000/  |k 1/60000/60200/  |k 2/60000/60200/60250/  |p 3 
998 |g 1075839017  |a Kleiner, Helga  |m 1075839017:Kleiner, Helga  |d 60000  |d 61200  |e 60000PK1075839017  |e 61200PK1075839017  |k 0/60000/  |k 1/60000/61200/  |p 2 
998 |g 1035534924  |a Prinzhorn, Wiltrud  |m 1035534924:Prinzhorn, Wiltrud  |d 60000  |d 61200  |e 60000PP1035534924  |e 61200PP1035534924  |k 0/60000/  |k 1/60000/61200/  |p 1  |x j 
999 |a KXP-PPN1514738422  |e 2861846593 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Wiltrud Haaß; Helga Kleiner; Christel Weiß; Claudia Haferlach; Brigitte Schlegelberger; Martin C. Müller; Rüdiger Hehlmann; Wolf-Karsten Hofmann; Alice Fabarius; Wolfgang Seifarth; Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung (SAKK) and the German CML Study Group"]},"person":[{"given":"Wiltrud","role":"oth","display":"Prinzhorn, Wiltrud","family":"Prinzhorn"},{"display":"Kleiner, Helga","family":"Kleiner","given":"Helga","role":"oth"},{"display":"Weiß, Christel","family":"Weiß","given":"Christel","role":"oth"},{"family":"Müller","display":"Müller, Martin Christian","role":"oth","given":"Martin Christian"},{"display":"Hehlmann, Rüdiger","family":"Hehlmann","role":"oth","given":"Rüdiger"},{"family":"Hofmann","display":"Hofmann, Wolf-Karsten","role":"oth","given":"Wolf-Karsten"},{"family":"Fabarius","display":"Fabarius, Alice","given":"Alice","role":"oth"},{"display":"Seifarth, Wolfgang","family":"Seifarth","given":"Wolfgang","role":"oth"}],"language":["eng"],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"recId":"1514738422","title":[{"title_sort":"Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapy","title":"Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapy"}],"relHost":[{"part":{"volume":"10","extent":"18","year":"2015","text":"10(2015,6) Artikel-Nr. e0129648, 18 S.","issue":"6"},"id":{"zdb":["2267670-3"],"eki":["523574592"],"issn":["1932-6203"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Schreibweise des Titels bis 2012: PLoS ONE","Gesehen am 20.03.19"],"type":{"media":"Online-Ressource","bibl":"periodical"},"pubHistory":["1.2006 -"],"corporate":[{"roleDisplay":"Herausgebendes Organ","display":"Public Library of Science","role":"isb"}],"language":["eng"],"recId":"523574592","origin":[{"dateIssuedKey":"2006","publisher":"PLOS ; PLoS","dateIssuedDisp":"2006-","publisherPlace":"San Francisco, California, US ; Lawrence, Kan."}],"disp":"Clonal evolution and blast crisis correlate with enhanced proteolytic activity of separase in BCR-ABL b3a2 fusion type CML under imatinib therapyPLOS ONE","title":[{"title_sort":"PLOS ONE","title":"PLOS ONE"}],"name":{"displayForm":["Public Library of Science"]}}],"note":["Gesehen am 27.08.2015"],"id":{"doi":["10.1371/journal.pone.0129648"],"eki":["1514738422"]},"physDesc":[{"extent":"18 S."}],"type":{"media":"Online-Ressource","bibl":"article-journal"}} 
SRT |a CLONALEVOL2015